Long intergenic non-protein coding RNA 690 (LINC00690)

Long intergenic non-protein coding RNA 690 (LINC00690) is a human long non-coding RNA (lncRNA) gene located on chromosome 3 (position 16,524,771-16,541,903, forward strand)[3][1][5][7]. It does not encode a protein but is part of a broader class of lncRNAs, many of which are increasingly recognized as regulators of gene expression, including roles in transcriptional and epigenetic regulation. LINC00690 itself has not been directly characterized as a therapeutic target or biomarker, but lincRNAs, more broadly, can play diverse regulatory roles and are studied in the context of cancers as potential contributors to molecular subtypes and disease progression[2]. Its locus has been associated with genome-wide association study (GWAS) variants, suggesting possible links to disease-relevant genetic architecture[5][7]. There is no evidence of direct drug interaction, nor well-validated functional or clinical implications specific to LINC00690 as of current knowledge. Additional details and context: - LINC00690 is annotated in Ensembl (ENSG00000233570) and NCBI Gene (100996597); there are no major synonyms or alternative names except its systematic designation[3][1]. - While many lincRNAs have demonstrated functional roles in cancer pathways—such as EMT, immune response, and proliferation—direct experimental evidence for LINC00690’s role is currently lacking. Some studies aggregate lncRNAs (like LINC00690) alongside others in multi-omics analyses of cancer, especially ovarian and endometrial cancers, where molecular profiling of lncRNA expression can inform disease classification[2][6]. - It is not considered a classic druggable “target” (such as a receptor or enzyme), and there are no approved or investigational drugs targeting LINC00690, nor any mechanisms of action described for such interventions. - GWAS data note intergenic variants that map to both the DAZL gene and LINC00690, but without direct evidence of pathological causality[5][7]. - There are no established biomarkers or safety data related to LINC00690. Summary: LINC00690 is a non-protein-coding lincRNA gene annotated in the human genome, recurrent in high-throughput studies of cancer transcriptomes but not—with current evidence—a direct therapeutic target, established biomarker, or subject of pharmacological intervention[1][2][3][5][7].

Other names

LINC00690